Literature DB >> 11407478

Transforming growth factor beta production by spontaneous malignant mesothelioma cell lines derived from Fisher 344 rats.

M Kuwahara1, M Takeda, Y Takeuchi, M Kuwahara1, T Harada, K Maita.   

Abstract

We investigated whether transforming growth factor beta (TGF-beta) is involved in the growth of malignant mesothelioma (MM) cells in culture. TGF-beta production was examined in two mesothelioma cell lines (MeET-4 and -6) that were established from rat spontaneous MM in our laboratory. TGF-beta bioactivity in conditioned medium of these cell lines was analyzed using a CCL64 mink lung epithelial cell growth inhibition assay and found to be 30-70 times higher than that of normal rat mesothelial cells (MCs). The MM cell lines also showed considerably higher levels of TGF-beta mRNA expression when compared with MCs. The bioactivity and mRNA expression level were greater in MeET-4 than MeET-6. When MeET-4 was treated with antisense TGF-beta1 oligonucleotide (ODN), a significant decrease in both anchorage-dependent and -independent growth was observed. Treatment with exogenous TGF-beta resulted in no effects on the growth pattern of the MM cell lines, while proliferation of the MCs was slightly induced. It is considered that TGF-beta appears to be produced by rat spontaneous MM cells through an autocrine mechanism and could modulate the malignant growth of the tumor cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11407478     DOI: 10.1007/s004280000363

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  2 in total

1.  Immunological alterations found in mesothelioma patients and supporting experimental evidence.

Authors:  Yoshie Miura; Yasumitsu Nishimura; Megumi Maeda; Shuko Murakami; Hiroaki Hayashi; Kazuya Fukuoka; Takumi Kishimoto; Takashi Nakano; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2008-02-28       Impact factor: 3.674

2.  Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients.

Authors:  James P Stevenson; Hedy L Kindler; Emmanouil Papasavvas; Jing Sun; Mona Jacobs-Small; Jennifer Hull; Daniel Schwed; Anjana Ranganathan; Kheng Newick; Daniel F Heitjan; Corey J Langer; John M McPherson; Luis J Montaner; Steven M Albelda
Journal:  Oncoimmunology       Date:  2013-08-27       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.